IP Verse

Sun Pharmaceutical Industries Ltd. et al. vs Merck Sharp & Dohme Corp. et al.

The detailed information for PTAB case with proceeding number IPR2020-01072 filed by Sun Pharmaceutical Industries Ltd. et al. against Merck Sharp & Dohme Corp. et al. on Jun 12, 2020. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2020-01072
Filing Date: Jun 12, 2020
Petitioner: Sun Pharmaceutical Industries Ltd. et al.
Respondent: Merck Sharp & Dohme Corp. et al.
Status: Final Written Decision
Respondent Application Number: 10874992
Respondent Tech Center: 1600
Respondent Patent Number: 7326708
Institution Decision Date: Sep 1, 2020
Termination Date: May 10, 2021

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
EXPUNGED	May 10, 2021	PAPER	BOARD
Termination Decision Document	May 10, 2021	PAPER	BOARD
Decision - Granting Institution of Inter Partes Review; Granting Motion for Joinder	Sep 1, 2020	PAPER	BOARD
Patent Owner's Preliminary Response	Aug 14, 2020	PAPER	PATENT OWNER
Petitioners¿¿¿ Joint Reply In Support Of Motions For Joinder	Jul 29, 2020	PAPER	PETITIONER
Ex. 1019 - Email from Merck to Joinder Petitioners Regarding Silent Understudy Conditions	Jul 29, 2020	EXHIBIT	PETITIONER
Ex. 1020 - Complaint, Merck Sharp & Dohme Corp. v. Dr. Reddy's Laboratories, Inc. et al., No. :20-cv-00847-RGA, ECF 1 (D. Del. June 24, 2020)	Jul 29, 2020	EXHIBIT	PETITIONER
Petitioner's Updated Exhibit List as of 07-29-2020	Jul 29, 2020	PAPER	PETITIONER
Decision, State of Israel Commissioner of Patents, Designs and Ex. 1021 - Trademarks, Teva Pharmaceutical Industries Ltd. Opposition to Merck Sharp & Dohme Corp. Patent Application No. 172563 (July 30, 2019)	Jul 29, 2020	EXHIBIT	PETITIONER
Ex. 1022 - Third Declaration of Leonard J. Chyall, Ph.D	Jul 29, 2020	EXHIBIT	PETITIONER
Patent Owner's Opposition to Motion for Joinder	Jul 10, 2020	PAPER	PATENT OWNER
Patent Owner's Exhibit List	Jul 10, 2020	PAPER	PATENT OWNER
EX2028 - 2020.06.26 Letter to Joinder Petitioners	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2029 - 2020.07.01 Email from Joinder Petitioners	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2032 - U.S. Patent No. 8,309,724	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2033 - WO 2013001457	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2034 - Sun Pharm Indus. Ltd. Corporate Action Report	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2035 - 2020.07.02 Email regarding Chorghade Deposition Date	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2037 - 2020.07.02 Email from Merck to Joinder Petitioners	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2038 - 2020.07.07 Email from Joinder Petitioners	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2027 - 2020.06.29 Email regarding Mylan Opposition to Schedule Change	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2030 - Excerpt of January 29, 2015 Trial Transcript with Dr. Chyalls Testimony	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2031 - Excerpt of Dr. Chyall's third declaration	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2036 - 2020.07.02 Email from Mylan Reserving Rights	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2039 - Teva Complaint	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2039 - Teva Complaint	Jul 10, 2020	EXHIBIT	PATENT OWNER
EX2040 - Sun Complaint	Jul 10, 2020	EXHIBIT	PATENT OWNER
Patent Owner's Mandatory Notices	Jul 1, 2020	PAPER	PATENT OWNER
Patent Owner's Power of Attorney	Jul 1, 2020	PAPER	PATENT OWNER
Ex. 3001	Jun 24, 2020	EXHIBIT	BOARD
Notice of Accord Filing Date	Jun 22, 2020	PAPER	BOARD
Ex. 1001 - U.S. Patent No. 7,326,708	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1004 - WO 03/004498 to Edmonson	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1005 - Brittain, "Polymorphism in Pharmaceutical Solids"	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1006 - Bastin et al. "Salt Selection and Optimisation [sic] Procedures for Pharmaceutical New Chemical Entities"	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1007 - U.S. Patent No 6,699,871	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1010 - Complete copy of the prosecution history of the '708 patent as available for download from the USPTO website	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1012 - U.S. Provisional Application No. 60/303,474, filed July 6, 2001	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1014 - Prescribing Information for Januvia	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1015 - Merck Sharpe & Dohme's Responses and Objections to Defendants' First Set of Joint Interrogatories (1-10)	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1008 - Orange Book Entry for Janumet	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1009 - Orange Book Entry for Januvia	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1011 - U.S. Patent No. 4,572,909	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1013 - Prescribing Information for Janumet	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1016 - Brown et al., Chemistry: The Central Science, 8th Revised Edition 615-618 (2002)	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1003 - CV of Steven Worth Baldwin	Jun 12, 2020	EXHIBIT	PETITIONER
Ex. 1017 - Declaration of Dr. Mukund Chorghade, Ph.D	Jun 12, 2020	EXHIBIT	PETITIONER
EXPUNGED	Jun 12, 2020	EXHIBIT	PETITIONER
Petitioner's Power of Attorney	Jun 12, 2020	PAPER	PETITIONER
Ex. 1002- Declaration of Dr. Steven W. Baldwin, Ph.D.	Jun 12, 2020	EXHIBIT	PETITIONER
IPR Petition '708	Jun 12, 2020	PAPER	PETITIONER
MOTION FOR JOINDER	Jun 12, 2020	PAPER	PETITIONER